Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors
Clinical trial NCT03525925 · COMPLETED
Trial details
- NCT number
- NCT03525925
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2020-02-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.